medical centre developments (gb) limitedEstimated Valuation
£235k
Pomanda estimates the enterprise value of MEDICAL CENTRE DEVELOPMENTS (GB) LIMITED at £235k based on a Turnover of £481.1k and 0.49x industry multiple (adjusted for size and gross margin).
medical centre developments (gb) limitedEstimated Valuation
£3.8m
Pomanda estimates the enterprise value of MEDICAL CENTRE DEVELOPMENTS (GB) LIMITED at £3.8m based on an EBITDA of £1m and a 3.73x industry multiple (adjusted for size and gross margin).
medical centre developments (gb) limitedEstimated Valuation
£12.6m
Pomanda estimates the enterprise value of MEDICAL CENTRE DEVELOPMENTS (GB) LIMITED at £12.6m based on Net Assets of £9.1m and 1.39x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Medical Centre Developments (gb) LimitedOverview
Medical Centre Developments (gb) Limited is a live company located in london, W1G 6NU with a Companies House number of 05582789. It operates in the development of building projects sector, SIC Code 41100. Founded in October 2005, it's largest shareholder is
medical centre holdings limited
with a 85% stake. Medical Centre Developments (gb) Limited is a mature,
micro sized company, Pomanda has estimated its turnover at
£481.1k with
rapid
growth in recent years.
Medical Centre Developments (gb) Limited Health Check
Pomanda's financial health check has awarded Medical Centre Developments (Gb) Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating4out of 5
4 Strong
3 Regular
4 Weak
Size
annual sales of £481.1k, make it smaller than the average company (£2.5m)
£481.1k - Medical Centre Developments (gb) Limited
£2.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 54%, show it is growing at a faster rate (7.2%)
54% - Medical Centre Developments (gb) Limited
7.2% - Industry AVG
Production
with a gross margin of 26.5%, this company has a comparable cost of product (26.5%)
26.5% - Medical Centre Developments (gb) Limited
26.5% - Industry AVG
Profitability
an operating margin of 212.6% make it more profitable than the average company (7.5%)
212.6% - Medical Centre Developments (gb) Limited
7.5% - Industry AVG
Employees
with 2 employees, this is below the industry average (7)
2 - Medical Centre Developments (gb) Limited
7 - Industry AVG
Pay Structure
on an average salary of £50.2k, the company has an equivalent pay structure (£50.2k)
£50.2k - Medical Centre Developments (gb) Limited
£50.2k - Industry AVG
Efficiency
resulting in sales per employee of £240.5k, this is less efficient (£287.9k)
£240.5k - Medical Centre Developments (gb) Limited
£287.9k - Industry AVG
Debtor Days
it gets paid by customers after 6 days, this is earlier than average (28 days)
6 days - Medical Centre Developments (gb) Limited
28 days - Industry AVG
Creditor Days
its suppliers are paid after 105 days, this is slower than average (32 days)
105 days - Medical Centre Developments (gb) Limited
32 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Medical Centre Developments (gb) Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 0 weeks, this is less cash available to meet short term requirements (11 weeks)
0 weeks - Medical Centre Developments (gb) Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 69.3%, this is a similar level of debt than the average (73.1%)
69.3% - Medical Centre Developments (gb) Limited
73.1% - Industry AVG
MEDICAL CENTRE DEVELOPMENTS (GB) LIMITED financials
EXPORT
Medical Centre Developments (Gb) Limited's latest turnover from October 2024 is estimated at £481.1 thousand and the company has net assets of £9.1 million. According to their latest financial statements, we estimate that Medical Centre Developments (Gb) Limited has 2 employees and maintains cash reserves of £181.3 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Oct 2024
Oct 2023
Oct 2022
Oct 2021
Oct 2020
Oct 2019
Oct 2018
Oct 2017
Oct 2016
Oct 2015
Oct 2014
Oct 2013
Oct 2012
Oct 2011
Oct 2010
Oct 2009
Turnover
481,088
619,006
1,580,991
132,636
167,567
41,963
69,612
241,204
2,627,839
8,178,308
5,738,677
12,633,793
4,841,759
5,599,171
6,040,797
Other Income Or Grants
Cost Of Sales
353,691
454,083
1,179,445
101,276
125,090
30,555
49,554
168,654
1,845,757
5,787,520
4,118,726
9,068,620
3,480,302
4,108,011
4,389,270
Gross Profit
127,397
164,924
401,546
31,360
42,477
11,408
20,058
72,550
782,082
2,390,788
1,619,951
3,565,173
1,361,456
1,491,160
1,651,527
Admin Expenses
-895,463
-740,927
5,866,643
-511,615
-1,353,038
-1,477,623
-587,841
-3,131,374
-3,296,340
1,759,253
1,210,848
3,394,082
1,223,494
1,445,246
1,534,891
-55,384
Operating Profit
1,022,860
905,851
-5,465,097
542,975
1,395,515
1,489,031
607,899
3,203,924
4,078,422
631,535
409,103
171,091
137,962
45,914
116,636
55,384
Interest Payable
576,650
614,007
467,095
357,135
368,267
419,163
430,187
407,979
417,115
442,800
223,590
84,109
84,109
Interest Receivable
9,861
8,917
1,494
80
102
395
1,445
649
315
426
446
705
686
889
765
35
Pre-Tax Profit
456,071
300,761
-5,930,698
185,920
1,027,349
1,070,263
179,157
2,796,594
3,661,621
189,161
185,959
171,796
138,649
46,803
33,292
-28,690
Tax
-114,018
-75,190
-35,325
-195,196
-203,350
-34,040
-531,353
-732,324
-37,832
-39,051
-39,513
-33,276
-12,169
-9,322
Profit After Tax
342,053
225,571
-5,930,698
150,595
832,153
866,913
145,117
2,265,241
2,929,297
151,329
146,908
132,283
105,373
34,634
23,970
-28,690
Dividends Paid
Retained Profit
342,053
225,571
-5,930,698
150,595
832,153
866,913
145,117
2,265,241
2,929,297
151,329
146,908
132,283
105,373
34,634
23,970
-28,690
Employee Costs
100,393
141,256
269,339
43,818
43,076
42,470
41,811
41,285
446,055
1,069,104
742,219
1,676,449
678,053
831,963
896,870
Number Of Employees
2
3
6
1
1
1
1
1
11
27
20
47
19
24
27
EBITDA*
1,022,860
905,851
-5,465,097
542,975
1,395,515
1,489,031
607,899
3,203,924
4,078,422
631,535
409,103
171,091
137,962
45,914
116,636
55,384
* Earnings Before Interest, Tax, Depreciation and Amortisation
Oct 2024
Oct 2023
Oct 2022
Oct 2021
Oct 2020
Oct 2019
Oct 2018
Oct 2017
Oct 2016
Oct 2015
Oct 2014
Oct 2013
Oct 2012
Oct 2011
Oct 2010
Oct 2009
Tangible Assets
12,103,858
9,175,513
8,461,075
6,552,057
4,271,397
2,986,225
Intangible Assets
Investments & Other
29,467,691
29,371,650
28,415,418
25,387,221
23,992,660
21,647,716
18,766,674
19,013,165
15,152,568
6,705,190
Debtors (Due After 1 year)
Total Fixed Assets
29,467,691
29,371,650
28,415,418
25,387,221
23,992,660
21,647,716
18,766,674
19,013,165
15,152,568
12,103,858
9,175,513
8,461,075
6,705,190
6,552,057
4,271,397
2,986,225
Stock & work in progress
Trade Debtors
8,937
26,697
15,047
17,643
26,970
6,466
11,038
6,467
152,980
14,440
62,589
941,699
20,048
53,877
73,683
20,435
Group Debtors
Misc Debtors
268,281
72,798
15
126,757
15
15
Cash
181,279
213,159
126,540
6,285
152,989
50,598
54,758
330,684
188,581
63,431
107,140
71,341
210,844
63,686
291,836
13,992
misc current assets
total current assets
190,216
239,856
409,868
96,726
179,974
183,821
65,811
337,166
341,561
77,871
169,729
1,013,040
230,892
117,563
365,519
34,427
total assets
29,657,907
29,611,506
28,825,286
25,483,947
24,172,634
21,831,537
18,832,485
19,350,331
15,494,129
12,181,729
9,345,242
9,474,115
6,936,082
6,669,620
4,636,916
3,020,652
Bank overdraft
158,800
150,232
142,130
133,740
Bank loan
234,200
221,548
209,582
198,264
187,559
177,435
167,858
Trade Creditors
102,000
101,981
350,709
9,090
427
47
443
54,073
439,896
2,312,477
1,433,820
1,709,603
1,288,357
1,455,877
1,530,037
286,002
Group/Directors Accounts
11,948,071
11,847,612
12,041,921
9,246,623
7,948,991
8,048,991
5,790,502
6,213,987
4,528,918
other short term finances
hp & lease commitments
other current liabilities
422,063
876,828
324,635
362,038
307,164
200,049
279,815
287,944
163,369
total current liabilities
12,706,334
13,047,969
12,926,847
9,816,015
8,444,141
8,426,522
6,238,618
6,714,804
5,282,415
2,454,607
1,567,560
1,709,603
1,288,357
1,455,877
1,530,037
286,002
loans
4,897,301
5,131,501
5,353,049
5,562,631
5,760,896
5,948,454
6,125,889
6,293,747
6,452,548
6,602,779
6,745,957
2,587,961
hp & lease commitments
Accruals and Deferred Income
other liabilities
1,556,282
1,276,099
1,336,866
1,397,633
1,458,400
6,879,695
5,312,338
4,983,729
3,111,499
175,279
provisions
1,404,736
1,574,893
1,297,557
952,445
904,569
684,086
562,416
581,335
263,962
total long term liabilities
7,858,319
7,982,493
7,987,472
7,912,709
8,123,865
6,632,540
6,688,305
6,875,082
6,716,510
6,602,779
6,745,957
6,879,695
5,312,338
4,983,729
3,111,499
2,763,240
total liabilities
20,564,653
21,030,462
20,914,319
17,728,724
16,568,006
15,059,062
12,926,923
13,589,886
11,998,925
9,057,386
8,313,517
8,589,298
6,600,695
6,439,606
4,641,536
3,049,242
net assets
9,093,254
8,581,044
7,910,967
7,755,223
7,604,628
6,772,475
5,905,562
5,760,445
3,495,204
3,124,343
1,031,725
884,817
335,387
230,014
-4,620
-28,590
total shareholders funds
9,093,254
8,581,044
7,910,967
7,755,223
7,604,628
6,772,475
5,905,562
5,760,445
3,495,204
3,124,343
1,031,725
884,817
335,387
230,014
-4,620
-28,590
Oct 2024
Oct 2023
Oct 2022
Oct 2021
Oct 2020
Oct 2019
Oct 2018
Oct 2017
Oct 2016
Oct 2015
Oct 2014
Oct 2013
Oct 2012
Oct 2011
Oct 2010
Oct 2009
Operating Activities
Operating Profit
1,022,860
905,851
-5,465,097
542,975
1,395,515
1,489,031
607,899
3,203,924
4,078,422
631,535
409,103
171,091
137,962
45,914
116,636
55,384
Depreciation
Amortisation
Tax
-114,018
-75,190
-35,325
-195,196
-203,350
-34,040
-531,353
-732,324
-37,832
-39,051
-39,513
-33,276
-12,169
-9,322
Stock
Debtors
-17,760
-256,631
192,887
63,456
-106,238
122,170
4,571
-146,498
138,540
-48,149
-879,110
921,651
-33,829
-19,806
53,248
20,435
Creditors
19
-248,728
341,619
8,663
380
-396
-53,630
-385,823
-1,872,581
878,657
-275,783
421,246
-167,520
-74,160
1,244,035
286,002
Accruals and Deferred Income
-454,765
552,193
-37,403
54,874
107,115
-79,766
-8,129
124,575
163,369
Deferred Taxes & Provisions
-170,157
277,336
345,112
47,876
220,483
121,670
-18,919
317,373
263,962
Cash flow from operations
301,699
1,668,093
-5,008,656
555,607
1,634,535
1,205,019
488,610
2,875,194
1,762,308
1,520,509
973,379
-368,827
-29,005
-20,609
1,298,101
320,951
Investing Activities
capital expenditure
12,103,858
-2,928,345
-714,438
-8,461,075
6,552,057
-2,280,660
-1,285,172
-2,986,225
Change in Investments
96,041
956,232
3,028,197
1,394,561
2,344,944
2,881,042
-246,491
3,860,597
15,152,568
-6,705,190
6,705,190
cash flow from investments
-96,041
-956,232
-3,028,197
-1,394,561
-2,344,944
-2,881,042
246,491
-3,860,597
-3,048,710
-2,928,345
-714,438
-1,755,885
-153,133
-2,280,660
-1,285,172
-2,986,225
Financing Activities
Bank loans
12,652
11,966
11,318
10,705
10,124
9,577
167,858
Group/Directors Accounts
100,459
-194,309
2,795,298
1,297,632
-100,000
2,258,489
-423,485
1,685,069
4,528,918
Other Short Term Loans
Long term loans
-234,200
-221,548
-209,582
-198,265
-187,558
-177,435
-167,858
-158,801
-150,231
-143,178
6,745,957
-2,587,961
2,587,961
Hire Purchase and Lease Commitments
other long term liabilities
280,183
-60,767
-60,767
-60,767
1,458,400
-6,879,695
1,567,357
328,609
1,872,230
2,936,220
175,279
share issue
170,157
444,506
6,086,442
-2,558,436
1,941,289
417,147
200,000
100
interest
-566,789
-605,090
-465,601
-357,055
-368,165
-418,768
-428,742
-407,330
-416,800
-442,374
-223,144
705
686
889
-83,344
-84,074
cash flow from financing
-237,538
-625,242
8,157,108
692,250
812,801
1,671,863
-852,227
1,118,938
1,403,451
1,355,737
-356,882
1,985,209
329,295
2,073,119
264,915
2,679,266
cash and cash equivalents
cash
-31,880
86,619
120,255
-146,704
102,391
-4,160
-275,926
142,103
125,150
-43,709
35,799
-139,503
147,158
-228,150
277,844
13,992
overdraft
-158,800
8,568
8,102
8,390
133,740
change in cash
-31,880
86,619
120,255
-146,704
102,391
-4,160
-117,126
133,535
117,048
-52,099
-97,941
-139,503
147,158
-228,150
277,844
13,992
medical centre developments (gb) limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for medical centre developments (gb) limited. Get real-time insights into medical centre developments (gb) limited's credit score, group structure and payment trends.
Medical Centre Developments (gb) Limited Competitor Analysis
Perform a competitor analysis for medical centre developments (gb) limited by selecting its closest rivals, whether from the CONSTRUCTION sector, other micro companies, companies in W1G area or any other competitors across 12 key performance metrics.
medical centre developments (gb) limited Ownership
MEDICAL CENTRE DEVELOPMENTS (GB) LIMITED group structure
Medical Centre Developments (Gb) Limited has no subsidiary companies.
MEDICAL CENTRE DEVELOPMENTS (GB) LIMITED Shareholders
The largest shareholders in Medical Centre Developments (Gb) Limited include Medical Centre Holdings Limited and Nigel Kevin Ford.
medical centre holdings limited
85%
nigel kevin ford
15%
medical centre developments (gb) limited directors
Medical Centre Developments (Gb) Limited currently has 3 directors.
The longest serving directors include
Mr Nigel Ford (Oct 2005) and
Mr Christopher Hobden (Oct 2005).
medical centre developments (gb) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 20 charges/mortgages relating to medical centre developments (gb) limited. Currently there are 19 open charges and 1 have been satisfied in the past.
medical centre developments (gb) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MEDICAL CENTRE DEVELOPMENTS (GB) LIMITED. This can take several minutes, an email will notify you when this has completed.
medical centre developments (gb) limitedCompanies House Filings - See Documents
